# Evaluation of Cardioverter Capacity of Amiodarone Pre-electrical Cardioversion in Persistent Atrial Fibrillation

> **NCT06645249** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Institut Investigacio Sanitaria Pere Virgili** · enrollment: 122 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)

## Interventions

- **DRUG:** Amiodarone (Antiarrhythmic drug)

## Key facts

- **NCT ID:** NCT06645249
- **Lead sponsor:** Institut Investigacio Sanitaria Pere Virgili
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-10
- **Primary completion:** 2026-09
- **Final completion:** 2026-10
- **Target enrollment:** 122 (ESTIMATED)
- **Last updated:** 2024-12-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06645249

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06645249, "Evaluation of Cardioverter Capacity of Amiodarone Pre-electrical Cardioversion in Persistent Atrial Fibrillation". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06645249. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*